Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye

PURPOSE: Two new drugs with mucin-inducing and secretion-promotive effects, rebamipide and diquafosol, were recently approved as topical dry-eye treatments. We report two cases in which the long-term use of mucin-inducing eye drops improved chronic ocular graft-versus-host disease (cGVHD)–related dr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Optom Vis Sci
Autors principals: Yamane, Mio, Ogawa, Yoko, Fukui, Masaki, Kamoi, Mizuka, Saijo-Ban, Yumiko, Yaguchi, Saori, Mukai, Shin, Kawakita, Tetsuya, Simmura, Shigeto, Tsubota, Kazuo
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2015
Matèries:
Clinical Cases
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376271/
https://ncbi.nlm.nih.gov/pubmed/25785527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/OPX.0000000000000523
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars